Ashwagandha
Prolanza
- Products
- 2
Additional safety flags
- hepatotoxicity_B
LiverTox Category B. 2019-2024: rising case reports of idiosyncratic hepatitis. Iceland DHPA 2024 advisory; EU scrutiny ongoing. Heightened risk with existing liver disease or concurrent hepatotoxic drugs.
LiverTox_NIH source →
Products containing Prolanza